The therapeutic effects of cyclacillin in acute sinusitis: in vitro and in vivo correlations in a placebo-controlled study.
D000284:Administration, Oral; D000328:Adult; D002986:Clinical Trials as Topic; D003514:Cyclohexylamines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D008297:Male; D008826:Microbial Sensitivity Tests; D009666:Nose / Q000382:microbiology; D010397:Penicillanic Acid / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D010406:Penicillins / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D010919:Placebos; D011512:Proteus Infections / Q000188:drug therapy*; D011513:Proteus mirabilis / Q000187:drug effects / Q000302:isolation & purification; D012852:Sinusitis / Q000188:drug therapy*; D013203:Staphylococcal Infections / Q000188:drug therapy*; D013210:Staphylococcus / Q000187:drug effects / Q000302:isolation & purification; D013997:Time Factors
D003514:Cyclohexylamines; D010406:Penicillins; D010919:Placebos; D010397:Penicillanic Acid